This page lists the SEC filings reported by VIKING GLOBAL INVESTORS LP.
| Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
|---|---|---|---|---|---|---|
| SC 13G | 2021-06-07 | VIKING GLOBAL INVESTORS LP | FIGS, Inc. | 14,942,689 | 10.1% | EDGAR |
| SC 13G | 2021-05-17 | VIKING GLOBAL INVESTORS LP | Talaris Therapeutics, Inc. | 3,289,617 | 8.2% | EDGAR |
| SC 13G | 2021-04-16 | VIKING GLOBAL INVESTORS LP | Mudrick Capital Acquisition Corp. II | 3,047,904 | 9.6% | EDGAR |
| SC 13G | 2021-04-05 | VIKING GLOBAL INVESTORS LP | Edgewise Therapeutics, Inc. | 3,352,281 | 7.0% | EDGAR |
| SC 13G | 2021-03-12 | VIKING GLOBAL INVESTORS LP | Orion Acquisition Corp. | 3,600,000 | 8.7% | EDGAR |
| SC 13G/A | 2021-02-16 | VIKING GLOBAL INVESTORS LP | Canada Goose Holdings Inc. | 0 | 0.0% | EDGAR |
| SC 13G/A | 2021-02-16 | VIKING GLOBAL INVESTORS LP | aTYR PHARMA INC | 0 | 0.0% | EDGAR |
| SC 13G/A | 2021-02-16 | VIKING GLOBAL INVESTORS LP | Chewy, Inc. | 0 | 0.0% | EDGAR |
| SC 13G/A | 2021-02-16 | VIKING GLOBAL INVESTORS LP | Vertex, Inc. | 0 | 0.0% | EDGAR |
| SC 13G/A | 2021-02-16 | VIKING GLOBAL INVESTORS LP | Change Healthcare Inc. | 0 | 0.0% | EDGAR |
| SC 13G/A | 2021-02-16 | VIKING GLOBAL INVESTORS LP | Adaptive Biotechnologies Corp | 29,993,708 | 21.9% | EDGAR |
| SC 13G/A | 2021-02-16 | VIKING GLOBAL INVESTORS LP | GoHealth, Inc. | 2,600,905 | 3.1% | EDGAR |
| SC 13G/A | 2021-02-16 | VIKING GLOBAL INVESTORS LP | Inhibrx, Inc. | 5,305,866 | 14.1% | EDGAR |
| SC 13G/A | 2021-02-16 | VIKING GLOBAL INVESTORS LP | PMV Pharmaceuticals, Inc. | 2,364,062 | 5.3% | EDGAR |
| SC 13G/A | 2021-02-16 | VIKING GLOBAL INVESTORS LP | Zentalis Pharmaceuticals, Inc. | 3,011,284 | 7.4% | EDGAR |
| SC 13G/A | 2021-02-16 | VIKING GLOBAL INVESTORS LP | Athira Pharma, Inc. | 2,120,653 | 6.0% | EDGAR |
| SC 13G/A | 2021-02-16 | VIKING GLOBAL INVESTORS LP | 4D Molecular Therapeutics Inc. | 3,937,914 | 14.9% | EDGAR |
| SC 13G/A | 2021-02-16 | VIKING GLOBAL INVESTORS LP | AbCellera Biologics Inc. | 19,283,744 | 7.2% | EDGAR |
| SC 13G | 2021-02-16 | VIKING GLOBAL INVESTORS LP | Pharvaris N.V. | 2,420,155 | 7.6% | EDGAR |
| SC 13G/A | 2021-02-12 | VIKING GLOBAL INVESTORS LP | Nuance Communications, Inc. | 16,382,663 | 5.8% | EDGAR |
- Form 13F-HR
- The 13F-HR report is filed quarterly to report securities held by the filer that fall under the SEC's 13F rules.
- Form SC 13D/G
- Reported by persons and groups who own 5% or more of any class of a company's outstanding shares. If the ownership changes by 1% or more, an amendment must be filed.
- Form 3, 4, and 5
- Form 3, 4, and 5 reports are filed to report insider transactions by company officers and directors, and any beneficial owners of more than ten percent of a company's shares. Form 3 is the initial report that must be filed when a person becomes an officer, director, or beneficial owner. Form 4 reports are used to report changes in ownership, while the Form 5 report is used for reporting transactions that should have been reported earlier in a Form 4 filing.